A new method to study the proteins released by cells could lead to the development of new tools to track diseases including cancer.
The method for finding new ‘biomarker’ proteins was developed by scientists at the Francis Crick Institute and Imperial College London.
Biomarkers are highly valuable tools that allow doctors to study biology and disease. For example, they can help diagnose a disease from a blood or tissue sample, predict if a treatment will be effective in an individual, or see how much of a drug is reaching diseased cells.
But finding these biomarkers is challenging. To help diagnose disease, scientists need to identify proteins that are uniquely made by diseased or cancerous cells but are not released by healthy cells.
In their study, published today in Nature Communications, the team developed a new method that identifies proteins released by a specific type of cell, even if the cells are in a complex environment with lots of other cell types.
Dr Ben Schumann, lead author and group leader at the Crick and Imperial College London, said: “When you have a sample containing various cell lines, it is very difficult to identify the proteins that came from a specific line. Of course, in the laboratory, we can create experiments with only one type of cell, however these conditions do not mirror what happens in the body where complex interactions between cells could affect their behaviour and so the proteins they release.”
The new method is centred around adding chemical tags to sugar molecules, which are added to cells. While all cells absorb the sugar, the researchers genetically modify the cell type they want to study, so that only this type adds the sugar to its proteins. When the cells make these proteins, they remain marked with the chemical tag, meaning that researchers can identify them.
The method uses bioorthogonal or ‘click’ chemistry, which was awarded this year’s Nobel Prize in Chemistry. One of the prize recipients, Carolyn Bertozzi from Stanford University, is a co-author of this study. The chemical tag is selected so that it ‘clicks’ with another molecule that helps the researchers isolate the desired proteins or add a fluorescent tag to them.
Understanding disease biology
The researchers showed their method, called Bio-Orthogonal Cell line-specific Tagging of Glycoproteins (BOCTAG), worked in cell cultures with multiple cell lines and also in mice, where the researchers successfully tagged proteins from particular cancer cells.
Dr Anna Cioce, first author and postdoctoral training fellow at the Crick, said: “In this study, we looked at proteins made by cancer cells, but our method could also be used in other fields including immunology or the study of infectious disease. It could also be used to better understand disease biology, including how tumour cells change as a result of complex interactions in the body.”
Dr Schumann added: “The next step for our team will be to continue developing this method and learning more about how cells produce different proteins depending on their environment.”
Based on a press release by the Francis Crick Institute.
‘Cell-specific Bioorthogonal Tagging of Glycoproteins’ by Cioce, A. et al. is published in Nature Communications.
Article text (excluding photos or graphics) © Imperial College London.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Tel: +44 (0)20 7594 2412
Show all stories by this author
Leave a comment
Your comment may be published, displaying your name as you provide it, unless you request otherwise. Your contact details will never be published.